三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
预计国内CRSwNP患者数量持续增加(亿人)
预计国内CRSwNP患者数量持续增加(亿人)
其它
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:76KB
图片尺寸:1211*849
同报告图片
/
4
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
所属报告:
智翔金泰-公司首次覆盖报告:聚焦抗体药物研发单品IL~17A单抗预计即将获批-240417(48页).pdf
打包全文图表
相关数据
全球已获批治疗CRSwNP生物制剂
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
收藏
行业数据
2024-12-05
原图定位
查看详情
预计全球CRSwNP患者基数较大(亿人)
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
收藏
其它
2024-06-21
原图定位
查看详情
国内外针对CRSwNP布局的管线基本为生物药
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
收藏
其它
2024-06-21
原图定位
查看详情
预计国内CRSwNP患者数量持续增加(亿人)
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
收藏
其它
2024-06-21
原图定位
查看详情
预计国内CRSwNP药物市场规模稳健增长
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
收藏
市场规模
2024-06-21
原图定位
查看详情
预计国内CRSwNP药物市场规模稳健增长
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
收藏
市场规模
2024-04-19
原图定位
查看详情
预计全球CRSwNP患者基数较大(亿人)
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
收藏
其它
2024-04-19
原图定位
查看详情
国内外针对CRSwNP布局的管线基本为生物药
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
收藏
其它
2024-04-19
原图定位
查看详情
CRSwNP市场规模预计2030年可超40亿元
fCDmnJ/pl7QgfCDlpI3lkIjlubTlop7plb/njocgfCDluILlnLrop4TmqKEgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS18CnwgMjAxOOW5tOiHszIwMjLlubQgfCAxMi4wJSB8IDkwLjAgfAp8IDIwMjLlubToh7MyMDI15bm0IHwgMjMuOSUgfCAxMDguNyB8CnwgMjAyNeW5tOiHszIwMzDlubQgfCAxOC42JSB8IDYzMy40IHwKCui1hOaWmeadpea6kO+8mkZyb3N0ICYgU3VsbGl2YW4=
收藏
其它
2024-02-26
原图定位
查看详情
目前全球仅三款CRSwNP治疗药物上市,国内尚无药物获批
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
收藏
其它
2024-02-26
原图定位
查看详情
预计国内CRSwNP药物市场规模稳健增长
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
收藏
市场规模
2024-02-22
原图定位
查看详情
预计全球CRSwNP患者基数较大(亿人)
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
收藏
其它
2024-02-22
原图定位
查看详情
预计国内CRSwNP患者数量持续增加(亿人)
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
收藏
其它
2024-02-22
原图定位
查看详情
国内外针对CRSwNP布局的管线基本为生物药
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
收藏
其它
2024-02-22
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
慢性鼻窦炎伴鼻息肉患者基数大,国内患者数量持续增加。CRSwNP 是慢性鼻窦炎的一个亚组,其特征是在鼻腔和鼻旁窦内出现肉质肿胀(鼻息肉),被认为是慢性炎症产生的。CRSwNP患者基数较大,根据 Frost & Sullivan数据统计,2021年全球 CRSwNP患者基数约 2.67亿人,预计 2030年约 3.11亿人,2021-2030 CAGR约1.7%;2022年国内 CRSwNP患者数量超 2000万人,预计 2030年患者基数约 2200万人,2021-2030 CAGR约 1.2%。
其它
原图定位
当前图表所属:
智翔金泰-公司首次覆盖报告:聚焦抗体药物研发单品IL~17A单抗预计即将获批-240417(48页).pdf
强直性脊柱关节炎二线治疗用药生物类抑制剂优势明显
针对银屑病治疗的生物药管线布局丰富
系统性治疗药物主要包括传统小分子药物、生物制剂与小分子靶向药物
2024年公司预计将新增20000L生物发酵产能
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》